Tumor-Stroma Ratio in ER+/HER2- Breast Cancer: Is it a Tool for Treatment Decision?

Elmhadi, Choukri; Allaoui, Mohammed; Zerrik, Meryem; Oukabli, Mohammed; Tanz, Rachid; Ichou, Mohammed

Elmhadi, Choukri; Allaoui, Mohammed; Zerrik, Meryem; Oukabli, Mohammed; Tanz, Rachid; Ichou, Mohammed.

Afiliação

Elmhadi C; Department of Medical Oncology, Mohammed V Military Teaching Hospital of Rabat, Morocco.
Allaoui M; School of Medicine and Pharmacy, University Hassan II, Casablanca, Morocco.
Zerrik M; Department of Pathology, Mohammed V Military Teaching Hospital of Rabat, Morocco.
Oukabli M; Department of Internal Medicine Mohammed V Military Teaching Hospital of Rabat, Morocco.
Tanz R; Department of Pathology, Mohammed V Military Teaching Hospital of Rabat, Morocco.
Ichou M; Department of Medical Oncology, Mohammed V Military Teaching Hospital of Rabat, Morocco.

Gulf J Oncolog ; 1(42): 14-21, 2023 May.

Article em En | MEDLINE | ID: mdl-37283255

Assuntos

Neoplasias da Mama; Humanos; Feminino; Neoplasias da Mama/patologia; Estudos Retrospectivos; Metástase Linfática; Terapia Combinada; Oncologia; Prognóstico

Palavras-chave

breast cancer; luminal; tumor-stroma ratio decision-support tool.

Buscar no Google

Imprimir

XML

PubMed Links

Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Gulf J Oncolog Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Marrocos

Buscar no Google

Imprimir

XML

PubMed Links